BioMed Research International

BioMed Research International / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 783698 |

Sanjay K. Jain, Alvaro Ordonez, Aarti Kinikar, Nikhil Gupte, Madhuri Thakar, Vidya Mave, Jennifer Jubulis, Sujata Dharmshale, Shailaja Desai, Swarupa Hatolkar, Anju Kagal, Ajit Lalvani, Amita Gupta, Renu Bharadwaj, "Pediatric Tuberculosis in Young Children in India: A Prospective Study", BioMed Research International, vol. 2013, Article ID 783698, 7 pages, 2013.

Pediatric Tuberculosis in Young Children in India: A Prospective Study

Academic Editor: Yanmin Hu
Received06 Aug 2013
Revised06 Nov 2013
Accepted11 Nov 2013
Published10 Dec 2013


Background. India has one of the highest tuberculosis (TB) burdens globally. However, few studies have focused on TB in young children, a vulnerable population, where lack of early diagnosis results in poor outcomes. Methods. Young children (≤5 years) with suspected TB were prospectively enrolled at a tertiary hospital in Pune, India. Detailed clinical evaluation, HIV testing, mycobacterial cultures, and drug susceptibility testing were performed. Results. 223 children with suspected TB were enrolled. The median age was 31 months, 46% were female, 86% had received BCG, 57% were malnourished, and 10% were HIV positive. 12% had TB disease (definite or probable), 35% did not have TB, while TB could not be ruled out in 53%. Extrapulmonary disease was noted in 46%, which was predominantly meningeal. Tuberculin skin test (TST) was positive in 20% of children with TB. Four of 7 (57%) children with culture-confirmed TB harbored drug-resistant (DR) strains of whom 2 (50%) were multi-DR (MDR). In adjusted analyses, HIV infection, positive TST, and exposure to household smoke were found to be significantly associated with children with TB ( ). Mortality (at 1 year) was 3 of 26 (12%) and 1 of 79 (1%), respectively, in children with TB and those without TB ( ). Conclusions. Diagnosis of TB is challenging in young children, with high rates of extra-pulmonary and meningeal disease. While the data on DR-TB are limited by the small sample size, they are however concerning, and additional studies are needed to more accurately define the prevalence of DR strains in this vulnerable population.

1. Introduction

India has one of the highest tuberculosis (TB) burdens globally, accounting for 20% of the new 8.6 million TB cases annually [1, 2]. While the burden of childhood TB in India is not known, regional data from the World Health Organization (WHO) indicate that sputum microscopy smear-positive TB in children (<14 years old) accounts for 0.6%–3.6% of all reported cases [3]. However, because the majority of children are sputum microscopy smear negative, these data underestimate the true burden of childhood TB. It is estimated that childhood TB constitutes 10–20% of all TB in high-burden countries [4], accounting for 8–20% of TB-related deaths [57]. The epidemiology of TB in young children (<5 years old), a vulnerable population where diagnosis and treatment are most challenging, is not well understood, especially in countries with limited public health resources. Furthermore, while several studies have described the pediatric TB epidemic in high HIV/TB coinfection settings such as sub-Saharan Africa [810], few studies have focused on TB during early childhood in India. Drug-resistant (DR) strains of Mycobacterium tuberculosis are highly prevalent (10–51%) in this region [11, 12], and young children are notoriously difficult to diagnose and treat [13]. In this report, we studied young children in Pune, India, and evaluated the prevalence of both TB and DR-TB. The recognition of TB in vulnerable populations is essential to better define the global TB epidemic and to help direct available healthcare resources.

2. Methods

2.1. Study Population

Young children (≤5 years) presenting with suspected TB were prospectively enrolled by consecutive sampling from August 15, 2010, to March 28, 2012, at the inpatient and outpatient facilities of the Byramjee Jeejeebhoy Government Medical College (BJGMC; formerly BJMC) and its affiliated private clinics in Pune, India. BJGMC is a large tertiary urban public hospital and the site of an NIH-funded HIV clinical trial unit (CTU). Suspected TB was defined as per the Indian Revised National TB Control Programme (RNTCP) guidelines [14, 15]. This includes children presenting with either fever and/or cough for ≥2 weeks (relaxed from 3 to 2 weeks), with or without weight loss or no weight gain, or showing neurological symptoms like irritability, refusal to feed, headache, vomiting, or altered sensorium and suspected to have TB meningitis. History of contact with a suspected or diagnosed case of TB disease (henceforth TB) within the last 2 years was not used to define a suspect (see Section 4). Exclusion criteria included the inability to obtain informed consent or permission for HIV testing, children on TB treatment or prophylaxis for more than 7 days, and children for whom followup was difficult. Consecutive children meeting the inclusion criteria were enrolled, and written, informed consent for enrolment was obtained from a parent or legal guardian. This study was approved by the Research Ethics Committees of BJGMC (Pune, India) and the Johns Hopkins University (Baltimore, MD).

2.2. Study Procedures

History and physical examination were performed on each child by trained study physicians. Weight for age Z scores (WAZ) were used to assess the nutritional status (WHO Anthro version 3.2.2, January 2011) with malnutrition defined as WAZ < −2. After appropriate counseling and consent, blood was drawn for HIV testing (positive on two separate HIV ELISA tests or HIV DNA PCR for children <18 months). A standard tuberculin skin test (TST) (5 TU in 0.1 mL; Radiant Parenterals, Ltd., Vaghodia, India) was placed during the initial visit and read at 48–72 hours. Since children were being evaluated for TB, a TST ≥ 5 mm was considered positive [16]. Gastric aspirates (up to 3 consecutive samples) and when indicated other appropriate clinical samples (lymph nodes, cerebrospinal fluid (CSF), pleural fluid, etc.) were obtained for mycobacterial culture. Chest radiographs were also performed on each child and those without highly consistent features of TB were reviewed independently by another radiologist. Computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography (US) were performed as indicated. All children were evaluated at 2 and 6 weeks after the initial visit and mortality data was collected for up to 1 year.

2.3. Microbiology

Clinical samples were processed at BJGMC by trained technicians using standardized protocols. Decontamination was performed with N-acetyl-L-cysteine and sodium hydroxide, and the resuspended pellets were used for acid fast bacilli (AFB) staining and smear microscopy as well as inoculation of Lowenstein Jensen (LJ) slants (one 3 mm loop full of sediment). The remaining ~0.5 mL was cultured using the MGIT 960 TB System (BD, Sparks, MD) and incubated for at least 6 weeks. Positive cultures were confirmed by p-nitrobenzoic acid (PNB) on the MGIT 960. Drug susceptibility testing (DST) for isoniazid (0.1 μg/mL) and rifampin (1.0 μg/mL) was performed using the SIRE kit (BD, Sparks, MD) and confirmed on solid media (proportion method). Genotypic methods, GeneXpert (Cepheid, Sunnyvale, CA; rifampin DST) and INNO-LiPA (Innogenetics NV, Gent, Belgium; isoniazid and rifampin DST), were also utilized.

2.4. Data Analysis

Children with suspected TB were classified into the TB diagnostic categories, definite TB (any clinical sample positive for M. tuberculosis by culture), probable TB (definition derived from international consensus guidelines [15, 17, 18]), no TB (negative mycobacterial cultures and documented resolution of symptoms without TB treatment), or possible TB (all other children), using an automatic computer algorithm and manually verified independently by the study PI. Noncontinuous variables were reported as frequencies and percentages and compared using Fisher’s exact test. Continuous variables were reported as medians and interquartile range (IQR) and compared using a Mann-Whitney nonparametric test. TB was defined as a child with either definite or probable TB and children in the no TB diagnostic category were defined as not having TB. Univariable and multivariable (adjusted) logistic regression analysis was used to estimate unadjusted and adjusted odds ratios and 95% CI. Known risk factors for TB were added to the multivariable model irrespective of their P value in the univariable analysis. In addition, a composite variable (exposure to household smoke) comprising the use of wood/biomass fuel for cooking or smoke exposure (smoker(s) in family) was used in the multivariable analysis. All analyses were performed using Excel 2010 (Microsoft, Redmond, WA) or Strata version 11.2 (StataCorp, College Station, TX).

3. Results

We screened 309 children with suspected TB and enrolled 223. Eighty six children were excluded: 15 on TB treatment for >7 days; 56 due to inability to followup; 15 due to inability to obtain informed consent (11 due to refusal of the gastric aspirate procedure; one due to transfer to another hospital before consent could be obtained, and three who refused to provide consent for unspecified reasons). The median age of the enrolled children was 31 months (IQR 14 to 44 months), 46% were female, 57% were malnourished, 86% had a BCG scar, and the parent was the primary caregiver for 97%. HIV results were available for 210 of the 223 children, and 21 (10%) were found to be positive. Twenty-six (12%) children were found to have TB (definite or probable), 79 (35%) did not have TB (no TB), while TB could not be ruled out in 118 (53%) and they were classified as possible TB (Figure 1). Characteristics of the enrolled children are listed in Table 1. No significant differences for age, sex, BCG status, and the primary caregiver were noted amongst the different TB diagnostic categories.

CharacteristicsAll, (100%)Definite TB, (3%)Probable TB, (9%)Possible TB, (53%)No TB, (35%) value

Age (months), median (IQR)31 (14–44)12 (6–36)27 (12–55)31 (13–43)31 (19–45)0.21
Female102/223 (46)3/7 (43)8/19 (42)55/118 (47)36/79 (46)0.99
Parent as primary caregiver212/219 (97)7/7 (100)19/19 (100)110/115 (96)76/78 (97)0.88
BCG scar192/222 (86)7/7 (100)16/19 (84)100/117 (85)69/79 (87)0.87
Malnourished128/223 (57)5/7 (71)9/19 (47)76/118 (64)38/79 (48)0.09
HIV positive21/210 (10)1/6 (17)5/15 (33)13/112 (12)2/77 (3)<0.01
TST positive27/215 (13)2/6 (33)3/19 (16)20/112 (18)2/78 (3)<0.01
 Urban65/222 (29)3/7 (43)4/19 (21)31/117 (26)27/79 (34) <0.01
 Periurban125/222 (56)3/7 (43)8/19 (42)65/117 (56)49/79 (62)
 Rural32/222 (14)1/7 (14)7/19 (37)21/117 (18)3/79 (4)
Smoker(s) in family110/194 (57)3/7 (43)7/14 (50)69/104 (66)31/69 (45)0.03
Cooking fuel
 LPG136/214 (64)5/7 (71)6/17 (35)67/112 (60)58/78 (74) <0.01
 Kerosene38/214 (18)0/7 (0)3/17 (18)20/112 (18)15/78 (19)
 Wood or biomass40/214 (19)2/7 (29)8/17 (47)25/112 (22)5/78 (6)
Mother’s education ≤ primary67/217 (31)3/7 (43)7/18 (39)43/113 (38)14/79 (18)0.01
Father’s education ≤ primary67/217 (31)4/7 (57)7/18 (39)37/114 (32)19/78 (24)0.19
Exposure to a known TB case in the past 2 years92/202 (46)4/7 (57)3/15 (20)52/109 (48)33/71 (46)0.20

IQR: interquartile range.

For children with TB, 12 of 26 (46%) had extrapulmonary disease, of whom 9 (75%) had TB meningitis. TST was positive in 5 of 25 (20%) of children with TB. Details of the children with definite TB are summarized in Table 2. Of the 7 children, 4 (57%) had extra-pulmonary TB (TB meningitis) and only 1 was HIV positive. DST was initially performed using MGIT and 4 of 7 (57%) children harbored DR strains of whom 2 (50%) were multi-DR (MDR).

IDAge in months Type of diseaseHIV status Disposition at 1 yearMGITSolid mediaGeneXpert RIFINNO-LiPA


INH: isoniazid; RIF: rifampin; S: sensitive; R: resistant.
3.1. Risk Factors Associated with TB

Children with TB were compared with those without TB. No significant differences for age, sex, rates of malnutrition, and BCG status were noted amongst these two groups. Children with TB were more likely to be HIV positive, be TST positive, reside in rural areas, be exposed to biomass cooking fuel, and have a mother with less than primary school education. In adjusted analyses, HIV infection (13.61; 95% confidence interval (CI) 1.44–128.74; ), positive TST (95.89; 95% CI 7.19–1278.51; ), and exposure to household smoke (7.43; 95% CI 1.12–49.47; ) were found to be significantly associated with children with TB. Interestingly, exposure to a known TB case in the past 2 years was not found to be associated with TB.

3.2. Initiation of TB Treatment and Mortality

Decision to initiate TB treatment was made independently by the treating physician. Children more likely to have TB (based on the TB diagnostic category) were also more likely to be started on TB treatment within the first 6 weeks ( ) (Table 3). HIV-infected children were more likely to be started on TB treatment (52%) compared with HIV uninfected or unknown patients ( ). Similarly, TST-positive children were also more likely to be started on TB treatment compared to those who were TST negative or unknown ( ). Mortality by 1 year after entry for children with TB was 3 of 26 (12%) and 1 of 79 (1%) among those without TB ( ). There was a nonsignificant trend towards increasing mortality in children more likely to have TB (based on the TB diagnostic category) ( ). Compared with HIV-negative children, HIV-positive children had a higher mortality ( ). However, compared with TST-negative children, those with positive TST did not have a higher mortality ( ). There were no significant differences between children with pulmonary or extra-pulmonary TB in initiation of TB treatment or mortality ( ).

Treatment initiated within 6 weeksMortality within 1 year
(%) value (%) value

Type of TB
 Pulmonary TB ( )12 (86%)0.642 (14%)0.56
 Extrapulmonary TB ( )10 (83%)1 (8%)
TB diagnostic category
 Definite TB ( )7 (100%)<0.011 (14%)0.08
 Probable TB ( )15 (79%)2 (11%)
 Possible TB ( )43 (36%)5 (4%)
 No TB ( )0 (0%)1 (1%)
HIV status
 HIV positive ( )11 (52%)0.065 (24%)<0.01
 HIV negative ( )50 (26%)1 (1%)
 HIV unknown ( )4 (31%)3 (23%)
Tuberculin skin test status
 TST positive ( )20 (74%)<0.011 (4%)0.05
 TST negative ( )44 (23%)6 (3%)
 TST unknown ( )1 (13%)2 (25%)

4. Discussion

BJGMC serves a poor and underprivileged population and, as expected, the majority of children (57%) were malnourished. As per the cultural practice in this region, the parent was the primary caregiver in the majority (97%). BCG coverage (86%) was similar to the national standard and it was interesting to note that the majority of children with TB (88%) had received prior BCG. While the prevalence of HIV in young children in India is not known, the prevalence nationally in adults is 0.40% and children (<15 years) account for 3.5% of the HIV burden [19, 20]. However, HIV rates are higher in Pune [21, 22], which is a key trucking point in India, and consistent with the higher HIV rates (10%) observed in this study.

We also evaluated the possible risk factors associated with TB. The rates of malnutrition were not different between children with TB compared with those without TB, possibly due to the overall high rates of malnutrition in this cohort. In adjusted analyses, HIV infection, positive TST, and exposure to household smoke were found to be significantly associated with TB. While a positive TST was an independent risk factor for TB, it had low sensitivity (20%) reaffirming that, while a positive TST is helpful, a negative TST does not rule out disease in young children. There are limited data and continued controversy about the association of air pollution and TB risk, and only one prior study has identified exposure to fire-wood smoke as a potential risk factor for TB among children [23]. Therefore, this is a new finding and needs additional followup. Interestingly, exposure to a known TB case in the past 2 years was also not found to be significantly associated with TB. While this may represent an overall high rate of TB in this region, the Revised Pediatric TB guidelines in India have relaxed this requirement [18].

Diagnosis of TB in young children is challenging, as they are less likely to produce adequate specimens for microscopy and culture and more likely to present with extra-pulmonary TB and the paucibacillary nature of childhood TB. Therefore, while culture is not the standard of care in India, we optimized TB detection by utilizing an automated liquid culture media system (MGIT). However, compared with other recently published studies (10.7–16%) [8, 24], the recovery of M. tuberculosis was lower (3%) and could be attributed to the high rates of extra-pulmonary TB (46%). While several clinical algorithms and scores for pediatric TB exist, none are sufficiently sensitive or specific. We tried to limit diagnostic bias by applying a rigorous definition for children with probable TB (Figure 1) derived from international consensus guidelines [15, 17, 18]. However, TB could not be definitely ruled out in 53% of TB suspects. It is possible that a longer followup could have made these diagnoses clearer. Interestingly, we found that the reporting of hilar/mediastinal lymphadenopathy, a chest radiography finding consistent with TB, was discordant in 39% of children, when the same study was read by two independent radiologists. Similar discordance in chest radiography performed for the diagnosis of TB in children has been reported previously [25, 26]. While the implications for clinical management of the TB diagnostic categories are unclear, it is reassuring to note that there was a trend correlating mortality by 1 year after entry with the TB diagnostic category, with increasing mortality in children more likely to have TB. Similarly, it is reassuring to note that children more likely to have TB (based on the TB diagnostic category) were also more likely to be started on TB treatment within the first 6 weeks.

Knowledge of region-specific prevalence of DR-TB in young children is extremely important for determining appropriate empiric treatments. A recent meta-analysis by Lew et al. showed that treatment outcomes were substantially worse in patients with DR-TB, which has important implications in resource-limited settings [27]. We therefore performed DST for all culture-confirmed isolates of M. tuberculosis which were initially performed using MGIT. While results on subsequent solid media cultures were concordant with MGIT, DST for one isolate (patient 158) was found to be discordant when tested using genotypic methods. This isolate was found to be resistant to both isoniazid and rifampin by phenotypic methods (liquid and solid culture) but susceptible by genotypic methods. While genotypic methods do not detect all resistance conferring mutations, discordance for both rifampin and isoniazid DST is less common [28]. Therefore, laboratory contamination or infection with more than one bacterial strain cannot be entirely ruled out. A recent cross-sectional study by Shah and Chilkar from Mumbai (near Pune) reported that 7% of children (mean age 6.8 years) had DR-TB, of whom 41% was MDR [29]. Interestingly, they reported a much higher rate of DR-TB (65%) in patients with extra-pulmonary disease, consistent with our results, where a large proportion (46%) had extra-pulmonary disease. However, the drug-resistance data should be interpreted with caution, as culture confirmation was successful only in a minority. Furthermore, BJGMC is a tertiary level center, serving a highly underprivileged population, and thus these data may not be fully generalizable nationally. Nonetheless, these data are definitely concerning, and additional studies are needed to more accurately define the prevalence of DR strains in this population.

Finally, it was interesting to note that M. tuberculosis strains causing central nervous system (CNS) disease seem to cluster together (see the supplementary figure in the Supplementary Material available online at This is consistent with several clinical reports and animal studies that have observed the association of specific M. tuberculosis strains/lineages with TB meningitis [3033] and suggests that M. tuberculosis may possess virulence factors which promote CNS disease [34, 35]. Further analyses of the genetic differences in these strains and detailed analyses of mutations conferring drug resistance are underway.

5. Conclusions

Diagnosis of TB is very challenging in young children, and current tools are inadequate. The rates of extra-pulmonary and meningeal TB are very high in this vulnerable population, making the task of definitive diagnosis even more challenging. Furthermore, while the data on DR-TB are limited by the small sample size in the current study, they are however concerning, and additional studies are needed to more accurately define the prevalence of DR in this population.

Authors’ Contribution

Alvaro Ordonez and Aarti Kinikar equally contributed to this paper.

Conflict of Interests

The authors do not have a commercial or other association that might pose a conflict of interests.


The authors would like to thank Dr. Gopal Khadse, M.D., BJGMC, Pune (India), and Dr. Amita Joshi, M.D., Grant Medical College, Mumbai (India), for help with reviewing the chest radiographs and for performing the INNO-LiPA testing, respectively. They would also like to thank Becton, Dickinson and Company (India), for donating a portion of the MGIT tubes used to perform the mycobacterial cultures. This study was funded by the NIH/NICHD Indo-US Program R03 HD061059-01 (Sanjay K. Jain) and Indian Council for Medical Research (Renu Bharadwaj). Funding from NIH 5U01AI069497 (Amita Gupta), Johns Hopkins Center for Global Health Faculty Grant (Sanjay K. Jain) the and the NIH Director’s New Innovator Award OD006492 (Sanjay K. Jain) are also acknowledged. The funders and donors had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.

Supplementary Materials

Supplementary Figure: Cluster dendogram for M. tuberculosis isolates from children with definite TB.

  1. Supplementary Figure


  1. TB India 2006 RNTCP status report—DOTS for all: all for DOTS
  2. “WHO Global tuberculosis report,” 2013 View at: Google Scholar
  3. T. J. John, V. M. Vashishtha, and S. M. John, “50 years of tuberculosis control in India: progress, pitfalls and the way forward,” Indian Pediatrics, vol. 50, no. 1, pp. 93–98, 2013. View at: Google Scholar
  4. B. J. Marais, A. C. Hesseling, R. P. Gie, H. S. Schaaf, and N. Beyers, “The burden of childhood tuberculosis and the accuracy of community-based surveillance data,” International Journal of Tuberculosis and Lung Disease, vol. 10, no. 3, pp. 259–263, 2006. View at: Google Scholar
  5. S. K. Kabra, R. Lodha, and V. Seth, “Tuberculosis in children: what has changed in last 20 years?” Indian Journal of Pediatrics, vol. 69, supplement 1, pp. S5–S10, 2002. View at: Google Scholar
  6. S. Swaminathan and B. Rekha, “Pediatric tuberculosis: global overview and challenges,” Clinical Infectious Diseases, vol. 50, supplement 3, pp. S184–S194, 2010. View at: Publisher Site | Google Scholar
  7. C. M. Perez-Velez and B. J. Marais, “Tuberculosis in children,” The New England Journal of Medicine, vol. 367, no. 4, pp. 348–361, 2012. View at: Google Scholar
  8. M. P. Nicol, L. Workman, W. Isaacs et al., “Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study,” The Lancet Infectious Diseases, vol. 11, no. 11, pp. 819–824, 2011. View at: Publisher Site | Google Scholar
  9. H. J. Zar, D. Hanslo, P. Apolles, G. Swingler, and G. Hussey, “Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study,” The Lancet, vol. 365, no. 9454, pp. 130–134, 2005. View at: Publisher Site | Google Scholar
  10. S. Liebeschuetz, S. Bamber, K. Ewer, J. Deeks, A. A. Pathan, and A. Lalvani, “Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study,” The Lancet, vol. 364, no. 9452, pp. 2196–2203, 2004. View at: Publisher Site | Google Scholar
  11. M. Pereira, S. Tripathy, V. Inamdar et al., “Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India,” Indian Journal of Medical Research, vol. 121, no. 4, pp. 235–239, 2005. View at: Google Scholar
  12. D. Almeida, C. Rodrigues, Z. F. Udwadia et al., “Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention,” Clinical Infectious Diseases, vol. 36, no. 12, pp. e152–e154, 2003. View at: Google Scholar
  13. S. Karande and S. B. Bavdekar, “Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India,” Emerging Infectious Diseases, vol. 8, no. 11, pp. 1360–1361, 2002. View at: Google Scholar
  14. “Technical and operational guidelines for tuberculosis control,” Revised National Tuberculosis Control Programme, View at: Google Scholar
  15. Y. K. Amdekar, “Consensus statement on childhood tuberculosis,” Indian Pediatrics, vol. 47, no. 1, pp. 41–55, 2010. View at: Publisher Site | Google Scholar
  16. L. Saiman and P. Colson, “Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents,” Pediatrics, vol. 114, no. 4, pp. 1175–1201, 2004. View at: Publisher Site | Google Scholar
  17. S. M. Graham, T. Ahmed, F. Amanullah et al., “Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel,” Journal of Infectious Diseases, vol. 205, supplement 2, pp. S199–S208, 2012. View at: Publisher Site | Google Scholar
  18. A. Kumar, D. Gupta, S. B. Nagaraja, V. Singh, G. R. Sethi, and J. Prasad, “Updated National Guidelines for Pediatric Tuberculosis in India,” Indian Pediatrics, vol. 50, pp. 301–306, 2013. View at: Google Scholar
  19. NACO, “HIV Sentinel Surveillance 2010-11,” Technical Brief, View at: Google Scholar
  20. NACO, NACO Annual Report, 2010-11,
  21. S. H. Mehta, A. Gupta, S. Sahay et al., “High HIV prevalence among a high-risk subgroup of women attending sexually transmitted infection clinics in Pune, India,” Journal of Acquired Immune Deficiency Syndromes, vol. 41, no. 1, pp. 75–80, 2006. View at: Publisher Site | Google Scholar
  22. A. Gupta, S. Mehta, S. V. Godbole et al., “Same-sex behavior and high rates of HIV among men attending sexually transmitted infection clinics in Pune, India (1993–2002),” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 4, pp. 483–490, 2006. View at: Publisher Site | Google Scholar
  23. R. Ramachandran, P. S. Indu, T. S. Anish, S. Nair, T. Lawrence, and R. S. Rajasi, “Determinants of childhood tuberculosis–a case control study among children registered under revised National Tuberculosis Control Programme in a district of South India,” Indian Journal of Tuberculosis, vol. 58, no. 4, pp. 204–207, 2011. View at: Google Scholar
  24. K. L. Therese, R. Gayathri, S. Balasubramanian, S. Natrajan, and H. N. Madhavan, “Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India,” Indian Journal of Medical Microbiology, vol. 30, no. 4, pp. 411–417, 2012. View at: Google Scholar
  25. S. A. George, C. A. Ko, H. L. Kirchner, J. R. Starke, T. A. Dragga, and A. M. Mandalakas, “The role of chest radiographs and tuberculin skin tests in tuberculosis screening of internationally adopted children,” Pediatric Infectious Disease Journal, vol. 30, no. 5, pp. 387–391, 2011. View at: Publisher Site | Google Scholar
  26. G. H. Swingler, G. Du Toit, S. Andronikou, L. van der Merwe, and H. J. Zar, “Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis,” Archives of Disease in Childhood, vol. 90, no. 11, pp. 1153–1156, 2005. View at: Publisher Site | Google Scholar
  27. W. Lew, M. Pai, O. Oxlade, D. Martin, and D. Menzies, “Initial drug resistance and tuberculosis treatment outcomes: Systematic review and meta-analysis,” Annals of Internal Medicine, vol. 149, no. 2, pp. 123–134, 2008. View at: Google Scholar
  28. A. Sandgren, M. Strong, P. Muthukrishnan, B. K. Weiner, G. M. Church, and M. B. Murray, “Tuberculosis drug resistance mutation database,” PLoS Medicine, vol. 6, no. 2, 2009. View at: Publisher Site | Google Scholar
  29. I. Shah and S. Chilkar, “Clinical profile of drug resistant tuberculosis in children,” Indian Pediatrics, vol. 49, no. 9, pp. 741–744, 2012. View at: Google Scholar
  30. D. G. De Viedma, M. Marín, S. Andrés, G. Lorenzo, M. J. Ruiz-Serrano, and E. Bouza, “Complex clonal features in an Mycobacterium tuberculosis infection in a two-year-old child,” Pediatric Infectious Disease Journal, vol. 25, no. 5, pp. 457–459, 2006. View at: Publisher Site | Google Scholar
  31. A. C. Hesseling, B. J. Marais, H. L. Kirchner et al., “Mycobacterial genotype is associated with disease phenotype in children,” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 10, pp. 1252–1258, 2010. View at: Google Scholar
  32. M. Caws, G. Thwaites, S. Dunstan et al., “The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis,” PLoS Pathology, vol. 4, no. 3, Article ID e1000034, 2008. View at: Google Scholar
  33. R. Hernandez Pando, D. Aguilar, I. Cohen et al., “Specific bacterial genotypes of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model,” Tuberculosis, vol. 90, no. 4, pp. 268–277, 2010. View at: Publisher Site | Google Scholar
  34. N. A. Be, W. R. Bishai, and S. K. Jain, “Role of Mycobacterium tuberculosis pknD in the Pathogenesis of central nervous system tuberculosis,” BMC Microbiology, vol. 12, article 7, 2012. View at: Publisher Site | Google Scholar
  35. N. A. Be, G. Lamichhane, and J. Grosset, “Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system,” Journal of Infectious Diseases, vol. 198, pp. 1520–1528, 2008. View at: Google Scholar

Copyright © 2013 Sanjay K. Jain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.